Chronic immune-mediated reaction syndrome as the cause of late graft mortality in living-donor liver transplantation for primary biliary cirrhosis

Transplantation Proceedings

Volumn 46, Issue 5, 2014, Pages 1438-1443

  Harimoto, N ^a   Ikegami, T ^a   Nakagawara, H ^a   Yamashita, Y I ^a   Yoshizumi, T ^a   Uchiyama, H ^a   Soejima, Y ^a   Ikeda, T ^a   Shirabe, K ^a   Aishima, S ^a   Oda, Y ^a   Maehara, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHOLESTASIS; CHRONIC GRAFT REJECTION; CHRONIC IMMUNE MEDIATED REACTION SYNDROME; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNE MEDIATED INJURY; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; PORTAL VEIN OBSTRUCTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SPLENECTOMY; VEIN OCCLUSION; GRAFT REJECTION; IMMUNOLOGY; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; RETROSPECTIVE STUDY; SURVIVAL RATE;

FEMALE; GRAFT REJECTION; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84902551119     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2014.02.021     Document Type: Article

References (29)

1. R.F. Liermann Garcia, C. Evangelista Garcia, P. McMaster, and J. Neuberger Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center Hepatology 33 2001 22 27
2. U. Khettry, N. Anand, and P.N. Faul et al. Liver transplantation for primary biliary cirrhosis: a long-term pathologic study Liver Transpl 9 2003 87 96
3. R. Kashyap, S. Safadjou, and R. Chen et al. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases - an analysis of the UNOS database J Gastrointest Surg 14 2010 1362 1369
4. J. Kaneko, Y. Sugawara, and S. Tamura et al. Long-term outcome of living donor liver transplantation for primary biliary cirrhosis Transpl Int 25 2012 7 12
5. S. Tamura, Y. Sugawara, and J. Kaneko et al. Recurrence of cholestatic liver disease after living donor liver transplantation World J Gastroenterol 14 2008 5105 5109
6. H. Haga, A. Miyagawa-Hayashino, and K. Taira et al. Histological recurrence of autoimmune liver diseases after living-donor liver transplantation Hepatol Res 37 Suppl 3 2007 S463 S469
7. E. Hashimoto, M. Taniai, and S. Yatsuji et al. Long-term clinical outcome of living-donor liver transplantation for primary biliary cirrhosis Hepatol Res 37 Suppl 3 2007 S455 S461
8. E. Hashimoto, M. Shimada, and S. Noguchi et al. Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study Liver Transpl 7 2011 588 595
9. M.G. Silveira, J.A. Talwalkar, and K.D. Lindor et al. Recurrent primary biliary cirrhosis after liver transplantation Am J Transplant 10 2010 720 726
10. D.A. Jacob, U.P. Neumann, and M. Bahra et al. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients Clin Transplant 20 2006 211 220
11. H. Egawa, Y. Nakanuma, and Y. Maehara et al. Disease recurrence plays a minor role as a cause for retransplantation after living-donor liver transplantation for primary biliary cirrhosis: a multicenter study in Japan Hepatol Res 43 2013 502 507
12. I.A. Rowe, K. Webb, and B.K. Gunson et al. The impact of disease recurrence on graft survival following liver transplantation: a single centre experience Transpl Int 21 2008 459 465
13. P. Charatcharoenwitthaya, S. Pimentel, and J.A. Talwalkar et al. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation Liver Transpl 13 2007 1236 1245
14. Y. Yonemura, A. Taketomi, and Y. Soejima et al. Validity of preoperative volumetric analysis of congestion volume in living donor liver transplantation using three-dimensional computed tomography Liver Transpl 11 2005 1556 1562
15. A. Taketomi, K. Morita, and T. Toshima et al. Living donor hepatectomies with procedures to prevent biliary complications J Am Coll Surg 211 2010 456 464
16. T. Ikegami, T. Toshima, and K. Takeishi et al. Bloodless splenectomy during liver transplantation for terminal liver diseases with portal hypertension J Am Coll Surg 208 2009 e1 e4
17. A. Demetris, D. Adams, and C. Bellamy et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel Hepatology 31 2000 792 799
18. Banff schema for grading liver allograft rejection: an international consensus document Hepatology 25 1997 658 663
19. D. Morioka, H. Egawa, and M. Kasahara et al. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis Liver Transpl 13 2007 80 90
20. S.S. Jakab, V.J. Navarro, and B.W. Colombe et al. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database Liver Transpl 13 2007 1405 1413
21. V. Balan, K. Ruppert, and A.J. Demetris et al. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Hepatology 48 2008 878 888
22. P. Manousou, V. Arvaniti, and E. Tsochatzis et al. Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity Liver Transpl 16 2010 64 73
23. R. Maruoka, N. Aoki, and M. Kido et al. Splenectomy prolongs the effects of corticosteroids in mouse models of autoimmune hepatitis Gastroenterology 145 2013 209 220
24. Banff Working Group, A.J. Demetris, O. Adeyi, and C.O. Bellamy et al. Liver biopsy interpretation for causes of late liver allograft dysfunction Hepatology 44 2006 489 501
25. Y. Nakazawa, H. Chisuwa, and A. Mita et al. Life-threatening veno-occlusive disease after living-related liver transplantation Transplantation 75 2003 727 730
26. M. Sebagh, D. Azoulay, and B. Roche et al. Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation Liver Transpl 17 2011 798 808
27. D. Cazals-Hatem, S. Hillaire, and M. Rudler et al. Obliterative portal venopathy: portal hypertension is not always present at diagnosis J Hepatol 54 2011 455 461
28. S.C. Abraham, P.S. Kamath, and B. Eghtesad et al. Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy Am J Surg Pathol 30 2006 1454 1461
29. Y. Nakanuma, G. Ohta, and K. Kobayashi et al. Histological and histometric examination of the intrahepatic portal vein branches in primary biliary cirrhosis without regenerative nodules Am J Gastroenterol 77 1982 405 413